# Mesenchymal Stem Cells for The Treatment of Knee Osteoarthritis (KOA).

> **NCT04893174** · PHASE1 · UNKNOWN · sponsor: **Meridigen Biotech Co., Ltd.** · enrollment: 6 (estimated)

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **BIOLOGICAL:** UMC119-06-05
- **DEVICE:** Hyaluronic acid

## Key facts

- **NCT ID:** NCT04893174
- **Lead sponsor:** Meridigen Biotech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-15
- **Primary completion:** 2024-09
- **Final completion:** 2025-06
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2023-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04893174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04893174, "Mesenchymal Stem Cells for The Treatment of Knee Osteoarthritis (KOA).". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04893174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*